These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20828604)

  • 41. Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling.
    Ning J; Louisse J; Spenkelink B; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2017 Sep; 91(9):3093-3108. PubMed ID: 28357488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
    Lin DX; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling.
    Rietjens IM; Boersma MG; Zaleska M; Punt A
    Toxicol In Vitro; 2008 Dec; 22(8):1890-901. PubMed ID: 18840518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical Interaction of Protein Cysteine Residues with Reactive Metabolites of Methyleugenol.
    Feng Y; Wang H; Wang Q; Huang W; Peng Y; Zheng J
    Chem Res Toxicol; 2017 Feb; 30(2):564-573. PubMed ID: 28107620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels.
    Tremmel R; Herrmann K; Engst W; Meinl W; Klein K; Glatt H; Zanger UM
    Arch Toxicol; 2017 Oct; 91(10):3329-3339. PubMed ID: 28326452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary Methyleugenol-deoxyadenosine Adduct as a Potential Biomarker of Methyleugenol Exposure in Rats.
    Feng Y; Wang S; Wang H; Peng Y; Zheng J
    J Agric Food Chem; 2018 Feb; 66(5):1258-1263. PubMed ID: 29328669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
    Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates.
    Kohn MC; Melnick RL
    Toxicology; 1996 Oct; 113(1-3):31-9. PubMed ID: 8901880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxicokinetics of methyleugenol in F344 rats and B6C3F₁ mice.
    Hong SP; Fuciarelli AF; Johnson JD; Graves SW; Bates DJ; Waidyanatha S; Smith CS
    Xenobiotica; 2013 Mar; 43(3):293-302. PubMed ID: 22876784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic rate constants for hydroquinone in F344 rat and human liver isolated hepatocytes: application to a PBPK model.
    Poet TS; Wu H; English JC; Corley RA
    Toxicol Sci; 2004 Nov; 82(1):9-25. PubMed ID: 15272136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
    Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
    Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo genotoxicity of methyleugenol in gpt delta transgenic rats following medium-term exposure.
    Jin M; Kijima A; Hibi D; Ishii Y; Takasu S; Matsushita K; Kuroda K; Nohmi T; Nishikawa A; Umemura T
    Toxicol Sci; 2013 Feb; 131(2):387-94. PubMed ID: 23074021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
    Bond JA; Csanády GA; Leavens T; Medinsky MA
    IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.